No one would suggest leaving potentially dangerous, untested drugs on the market. But an outright ban hinders valuable research on compounds that could hold clues to treatments for diseases like Alzheimer’s.
No one would suggest leaving potentially dangerous, untested drugs on the market. But an outright ban hinders valuable research on compounds that could hold clues to treatments for diseases like Alzheimer’s.